Factors Associated With Nonresponse to FMT Identified in IBS
MONDAY, March 21, 2022 (HealthDay News) -- For patients with irritable bowel syndrome (IBS), those who are male and/or have low Alistipes levels are more likely to be nonresponders to fecal microbiota transplantation (FMT), according to a study published online March 18 in Neurogastroenterology & Motility.
Magdy El-Salhy, M.D., Ph.D., from Stord Hospital in Norway, and colleagues included 109 patients who received allogeneic FMT to examine factors potentially affecting FMT response. At baseline and at two weeks, one month, and three months after FMT, patients completed questionnaires that assessed their symptoms and quality of life. Fecal samples were also provided at baseline and one month after FMT.
The researchers found that age, IBS duration, IBS subtype, IBS symptoms, fatigue, quality of life, and dysbiosis index did not determine patient response or nonresponse to FMT. Among men, there were more nonresponders than responders. Compared with responders, nonresponders had lower fluorescence signals of Alistipes.
"This study has revealed that male IBS patients and IBS patients with low fecal Alistipes levels are not likely to respond to FMT treatment," the authors write. "Further studies are needed to establish whether Alistipes levels can be used as indicator to the FMT outcome."
Related Posts
Admission Less Likely for COVID-19 Patients With Omicron Versus Delta
FRIDAY, May 6, 2022 (HealthDay News) -- Patients with severe acute respiratory...
Screen Time at Age 1 Year Tied to Worse Later Developmental Performance
FRIDAY, Sept. 22, 2023 (HealthDay News) -- Increased TV/DVD screen time at 1 and...
Las vacunas contra la COVID salvan vidas, independientemente del peso corporal
MARTES, 5 de julio de 2022 (HealthDay News) -- La vacunación contra la COVID...
Ob/Gyn Tests Stay Virtual Due to Fears Around COVID, Abortion Ruling
TUESDAY, July 19, 2022 (HealthDay News) -- In light of the Supreme Court's...